Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent

APO866 is a small molecule drug that specifically inhibits nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme involved in nicotinamide adenine dinucleotide (NAD) biosynthesis from the natural precursor nicotinamide. Although, the antitumor activity of APO866 on various types of cancer mode...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Cloux, Anne-Julie, Aubry, Dominique, Heulot, Mathieu, Widmann, Christian, ElMokh, Oussama, Piacente, Francesco, Cea, Michele, Nencioni, Alessio, Bellotti, Axel, Bouzourène, Karima, Pellegrin, Maxime, Mazzolai, Lucia, Duchosal, Michel A., Nahimana, Aimable
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6877101/
https://ncbi.nlm.nih.gov/pubmed/31803365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27336
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados